Journals / Üroonkoloji Bülteni / 2018 / Cilt: 17 - Sayı: 3

The Effect of Transrectal Ultrasound-guided Prostate Needle Biopsy on Lower Urinary Tract Symptoms

Pages
89–93
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The procedure may decrease symptoms in patients with low education level due to the placebo effect.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: To evaluate the effect of transrectal ultrasound-guided prostate biopsy on lower urinary system symptoms.
📊
Key Findings & Data:Materials and Methods: The study included 123 patients who underwent ultrasound-guided prostate biopsy between March 2013 and December 2013.
💡
Conclusion & Impact:The procedure may decrease symptoms in patients with low education level due to the placebo effect.
🔬Design:Survey & Empirical Study
📍Scope:2013 Verileri
⚙️Variables:Domain Parameters

Özet

Objective: To evaluate the effect of transrectal ultrasound-guided prostate biopsy on lower urinary system symptoms. Materials and Methods: The study included 123 patients who underwent ultrasound-guided prostate biopsy between March 2013 and December 2013. Before and at 2, 4, and 8 weeks after the procedure, the patients completed the International Prostate Symptom Score (IPSS) questionnaire. Storage symptoms (questions 2, 4, 7) and voiding/postvoiding symptoms (questions 1, 3, 5, 6) were separately evaluated. The patients with cancer diagnosis were excluded after the week 4. The cancer-free patients were divided into subgroups based on education level and complication status and followed for 8 weeks to assess changes in IPSS and quality of life. Results: IPSS increased significantly at week 2 follow-up of both the cancerous and cancer-free patients (p=0.041 and p<0.01); however, there was no statistically significant difference between the pre-biopsy scores and week 4 scores (p=0.07 and p=0.09). Voiding/postvoiding symptoms also increased significantly at week 2 for both groups (p=0.04 and p<0.01, respectively). IPSS was significantly higher in all subgroups of cancer-free patients at week 2, in correlation with voiding/postvoiding symptoms. In patients with low education level, there was a significant decrease in IPSS at 4 and 8 weeks compared to pre-biopsy (p=0.031 and p=0.035, respectively). IPSS changes were not associated with prostate volume. Quality of life was significantly reduced in the early period (p<0.01). Conclusion: Lower urinary system symptoms are affected negatively in the early post-biopsy period in correlation with the increase of voiding/ postvoiding symptoms. The time required for remission is 15-30 days. The procedure may decrease symptoms in patients with low education level due to the placebo effect.

🔖

Cite This Article

ÇAĞAN, V., ÖNER, S., ÖNEN, E., AVCI, S., AYDOS, M. M., DEMİRBAŞ, M. (2018). The Effect of Transrectal Ultrasound-guided Prostate Needle Biopsy on Lower Urinary Tract Symptoms. Üroonkoloji Bülteni, Cilt: 17 - Sayı: 3, 89–93. https://ajindex.com/articles/334396

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hodge KK, McNeal JE, Terris MK, Stamey TA. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 1989;142:71-74.
  2. Ferlay J, Shin HR, Bray F, et al. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010;127:2893-2917.
  3. Loeb S, Vellekoop A, Ahmed HU, et al. Systematic review of complications of prostate biopsy. Eur Urol 2013;64:876-892.
  4. Heidenreich A, Bastian PJ, Bellmunt J, et al. EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013. Eur Urol 2014;65:124-137.
  5. Ganeswaran D, Sweeney C, Yousif F, et al. Population-based linkage of health records to detect urological complications and hospitalisation following transrectal ultrasound-guided biopsies in men suspected of prostate cancer. World J Urol 2014;2014:32:309-315.
  6. Li H, Yan W, Zhou Y, et al. Transperineal ultrasound-guided saturation biopsies using 11-region template of prostate: report of 303 cases. Urology 2007;70:1157-1161
  7. Chiang IN, Chang SJ, Pu YS, et al. Major complications and associated risk factors of transrectal ultrasound guided prostate needle biopsy: a retrospective study of 1875 cases in taiwan. J Formos Med Assoc 2007;106:929-934.
  8. Klein T, Palisaar RJ, Holz A, et al. The impact of prostate biopsy and periprostatic nerve block on erectile and voiding function: a prospective study. J Urol 2010;184:1447-1452.
  9. Helfand BT, Glaser AP, Rimar K, et al. Prostate cancer diagnosis is associated with an increased risk of erectile dysfunction after prostate biopsy. BJU Int 2013;111:38-43.
  10. Fujita K, Landis P, McNeil BK, Pavlovich CP. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol 2009;182:2664-2669.
  11. Zisman A, Leibovici D, Kleinmann J, et al. The impact of prostate biopsy on patient well-being: a prospective study of voiding impairment. J Urol 2001;166:2242-2246.
  12. Heidenreich A, Bellmunt J, Bolla M, et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011;59:61-71.
  13. Bjurlin MA, Carter HB, Schellhammer P, et al. Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing. J Urol 2013;189:2039-2046.
  14. Schoots IG, Roobol MJ, Niebboer D, et al. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer det